Cervical cancer screening with naked-eye visual inspection in Colombia

International Journal of Gynecology and Obstetrics

Volumn 109, Issue 3, 2010, Pages 230-234

  Murillo, Raul ^a   Luna, Joaquin ^a   Gamboa, Oscar ^a   Osorio, Elkin ^b   Bonilla, Jairo ^c   Cendales, Ricardo ^a  

^a Instituto Nacional de Cancerología   (Colombia)

^b Laboratorio salud Pública   (Colombia)

^c Fundacion Universitaria de Ciencias de la Salud   (Colombia)

Author keywords

Cytology; Latin America; Mass screening; Sensitivity and specificity; Uterine cervical neoplasms; Visual inspection

Indexed keywords

ACETIC ACID; LUGOL;

ADULT; ARTICLE; CANCER CONTROL; CANCER SCREENING; CLINICAL EXAMINATION; COLOMBIA; COLPOSCOPY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; CYTOPATHOLOGY; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; NAKED EYE VISUAL INSPECTION; NURSE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; UTERINE CERVIX BIOPSY; UTERINE CERVIX CANCER;

EID: 77951632394     PISSN: 00207292     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijgo.2010.01.019     Document Type: Article

References (25)

1. Denny L., Quinn M., and Sankaranarayanan R. Chapter 8: screening for cervical cancer in developing countries. Vaccine 24 Suppl. 3 (2006) S3/71-7
2. Murillo R., Almonte M., Pereira A., Ferrer E., Gamboa O.A., Jeronimo J., et al. Cervical cancer screening programs in Latin America and the Caribbean. Vaccine 26 Suppl. 11 (2008) L37-L48
3. Goldie S.J., Gaffikin L., Goldhaber-Fiebert J.D., Gordillo-Tobar A., Levin C., Mahé C., et al. Cost-effectiveness of cervical cancer screening in five developing countries. New Engl J Med 353 20 (2005) 2158-2168
4. Goldie S.J., Goldhaber-Fiebert J.D., and Garnett G.P. Chapter 18: Public health policy for cervical cancer prevention: The role of decision science, econocmic evaluation, and mathematical modeling. Vaccine 24 Suppl. 3 (2006) S3/155-63
5. Sankaranarayanan R., Esmy P.O., Rajkumar R., Mowonge R., Swaminathan R., Shanthakumar S., et al. Effect of visual screening on cervical incidence and mortality in Tamil Nadu, India: a cluster-randomised trial. Lancet 370 9585 (2007) 398-406
6. Almonte M., Ferreccio C., Winkler J.L., Cuzick J., Tsu V., Robles S., et al. Cervical cancer screening by visual inspection, HPV testing, liquid-based and conventional cytology in Amazonian Peru. Int J Cancer 121 4 (2007) 796-802
7. Sarian L.O., Derchain S.F., Naud P., Roteli-Martins C., Longatto-Filho A., Tatti S., et al. Evaluation of visual inspection with acetic acid (VIA), Lugol's iodine (VILI), cervical cytology and HPV testing as cervical screening tools in Latin America. J Med Screen 12 3 (2005) 142-149
8. Instituto Nacional de Cancerología de Colombia. Guidelines for screening of cervical cancer and preneoplasic lesions among Colombian women without history of cervical disease. Section III: Expert consensus. Guía de práctica clínica No. 3 (2007), INC, Bogotá
9. In: Sellors J., and Sankaranarayanan R. (Eds). Colposcopy and Treatment of Cervical Intraepithelial Neoplasia. A Beginner's Manual (2003), IARC Press, Lyon
10. Solomon D., Davey D., Kurman R., Moriarty A., O'Connor D., Prey M., et al. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA 287 16 (2002) 2114-2119
11. Mora M. Technical guidelines for the cytopathology laboratory (2007), Secretaría Distrital de Salud, Bogotá
12. Sankaranarayanan R., and Wesley R. A practical manual on visual screening for cervical neoplasia (2003), IARC Press, Lyon
13. Shastri S.S., Dinshaw K., Amin G., Goswami S., Patil S., Chinoy R., et al. Concurrent evaluation of visual, cytological and HPV testing as screening methods for the early detection of cervical neoplasia in Mumbai, India. Bull World Health Organ 83 3 (2005) 186-194
14. Ferris D.G., and Greenberg M.D. Reid's Colposcopic Index. J Fam Pract 39 1 (1994) 65-70
15. International Agency for Research on Cancer. Cervix cancer screening. IARC Working Group on the Evaluation of Cancer-Preventive Strategies. IARC Handbooks of Cancer Prevention 10 (2004), IARC Press, Lyon
16. Claeys P., De Vuyst H., Gonzalez C., Garcia A., Bello R.E., and Temmerman M. Performance of the acetic acid test when used in field conditions as a screening test for cervical cancer. Trop Med Int Health 8 8 (2003) 704-709
17. Barreth D., Schepansky A., Capstick V., Johnson G., Steed H., and Faught W. Atypical squamous cells-cannot exclude high-grade squamous intraepithelial lesion (ASC-H): a result not to be ignored. J Obstet Gynaecol Can 28 12 (2006) 1095-1098
18. Pitman M.B., Cibas E.S., Powers C.N., Renshaw A.A., and Frable W.J. Reducing or eliminating use of the category of atypical squamous cells of undetermined significance decreases the diagnostic accuracy of the Papanicolaou smear. Cancer 96 3 (2002) 128-134
19. Sankaranarayanan R., Basu P., Wesley R., Mahé C., Keita N., Gombe C., et al. Accuracy of visual screening for cervical neoplasia: Results from an IARC multicentre study in India and Africa. Int J Cancer 110 6 (2004) 907-913
20. Pérez-Cruz E., Winkler J.L., Velasco-Mondragón E., Salmerón-Castro J., García F., Tsu V.D., et al. Screening and follow-up for cervical cancer prevention in rural Mexico using visual inspection. Salud Publica Mex 47 1 (2005) 39-48
21. Bhatla N., Mukhopadhyay A., Joshi S., Kumar A., Kriplani A., Pandey R.M., et al. Visual inspection for cervical cancer screening: evaluation by doctor versus paramedical worker. Indian J Cancer 41 1 (2004) 32-36
22. Baum M.E., Rader J.S., Gibb R.K., McAlister R.P., Powell M.A., Mutch D.G., et al. Colposcopic accuracy of obstetrics and gynecology residents. Gynecol Oncol 103 3 (2006) 966-970
23. Franco E.L., Cuzick J., Hildesheim A., and de Sanjosé S. Chapter 20: Issues in planning cervical cancer screening in the era of HPV vaccination. Vaccine 24 Suppl. 3 (2006) S3/171-7
24. Sankaranarayanan R., Nene B.M., Shastri S.S., Jayant K., Muwonge R., Budukh A.M., et al. HPV screening for cervical cancer in rural India. N Engl J Med 360 14 (2009) 1385-1394
25. Qiao Y.L., Sellors J.W., Eder P.S., Bao Y.P., Lim J.M., Zhao F.H., et al. A new HPV-DNA test for cervical-cancer screening in developing regions: a cross-sectional study of clinical accuracy in rural China. Lancet Oncol 9 10 (2008) 929-936